Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cytek Biosciences (CTKB) Interest Expenses (2020 - 2025)

Cytek Biosciences' Interest Expenses history spans 6 years, with the latest figure at -$725000.0 for Q4 2025.

  • For Q4 2025, Interest Expenses rose 87.78% year-over-year to -$725000.0; the TTM value through Dec 2025 reached $474000.0, up 109.05%, while the annual FY2025 figure was $474000.0, 109.05% up from the prior year.
  • Interest Expenses reached -$725000.0 in Q4 2025 per CTKB's latest filing, down from $494000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $687000.0 in Q4 2022 to a low of -$5.9 million in Q4 2024.
  • Average Interest Expenses over 5 years is $81000.0, with a median of $437000.0 recorded in 2021.
  • Peak YoY movement for Interest Expenses: skyrocketed 43200.0% in 2021, then plummeted 1605.84% in 2024.
  • A 5-year view of Interest Expenses shows it stood at $492000.0 in 2021, then skyrocketed by 39.63% to $687000.0 in 2022, then plummeted by 42.65% to $394000.0 in 2023, then tumbled by 1605.84% to -$5.9 million in 2024, then skyrocketed by 87.78% to -$725000.0 in 2025.
  • Per Business Quant, the three most recent readings for CTKB's Interest Expenses are -$725000.0 (Q4 2025), $494000.0 (Q3 2025), and $414000.0 (Q2 2025).